Skip to main content

Want a detailed portfolio tracker?

Lunai Bioworks (LNAI) P/E (2015 - 2026)

Lunai Bioworks (LNAI) P/E from Feb 2, 2015 to Jul 21, 2026. The TTM Lunai Bioworks (LNAI) P/E is -26.73. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Lunai Bioworks (LNAI)

YearP/EChange
2026-26.73+1076.95%
2025-2.27+115.45%
2024-1.05-85.59%
2023-7.32+1380.31%
2022-0.49-94.97%
2021-9.84-21.72%
2020-12.57-57.48%
2019-29.55+137.93%
2018-12.42-95.97%
2017-308.52+370.34%
2016-65.60-47.60%
2015-125.18N/A

Comparison Lunai Bioworks (LNAI) P/E with competitors

Lunai Bioworks (LNAI) P/E is -26.73.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.28%
FGENFibroGen Inc0.24-100.90%
CHRSCoherus Biosciences Inc0.85-103.17%
FBIOFortress Biotech Inc0.95-103.55%
ORMPOramed Pharmaceuticals Inc1.50-105.62%
AGENAgenus Inc3.01-111.26%
INVAInnoviva Inc3.15-111.80%
VXRTVaxart Inc3.55-113.28%
CRMDCorMedix Inc3.63-113.57%
CVACCureVac N.V.4.45-116.63%
GLPGGalapagos NV4.86-118.18%
SRPTSarepta Therapeutics Inc4.88-118.26%
ABEOAbeona Therapeutics Inc5.39-120.15%
ABUSArbutus Biopharma Corp5.60-120.93%
ZVRAZevra Therapeutics Inc5.89-122.02%
SPROSpero Therapeutics Inc6.23-123.30%
CGENCompugen Ltd6.31-123.62%
RIGLRigel Pharmaceuticals6.87-125.71%
SLXNSilexion Therapeutics Corp7.30-127.29%
OMEROmeros Corporation9.26-134.63%
AUPHAurinia Pharmaceuticals Inc9.58-135.86%
PLXProtalix BioTherapeutics Inc10.89-140.74%
ACADAcadia Pharmaceuticals Inc11.73-143.87%
TBPHTheravance Biopharma Inc12.26-145.87%
ADMAAdma Biologics Inc12.42-146.45%
HRMYHarmony Biosciences Holdings Inc13.82-151.70%
SABSSAB Biotherapeutics Inc14.14-152.88%
NAGENiagen Bioscience Inc14.82-155.43%
INCYIncyte Corp15.82-159.19%
REGNRegeneron Pharmaceuticals Inc15.86-159.32%
PBYIPuma Biotechnology Inc17.32-164.77%
CPRXCatalyst Pharmaceuticals Inc17.44-165.24%
EXELExelixis Inc17.54-165.61%
TGTXTG Therapeutics Inc18.97-170.95%
MDXGMimedx Group Inc20.55-176.88%
XOMAXOMA Royalty Corp22.87-185.57%
ARGXArgen X SE24.30-190.90%
CTMXCytomX Therapeutics Inc24.82-192.85%
XOMAOXOMA Royalty Corp25.34-194.81%
HALOHalozyme Therapeutics Inc25.62-195.86%
XOMAPXOMA Royalty Corp25.67-196.03%
VRTXVertex Pharmaceuticals Inc27.99-204.73%
RPRXRoyalty Pharma plc - Class A28.69-207.32%
SLNOSoleno Therapeutics Inc29.02-208.54%
ASNDAscendis Pharma A/S30.09-212.55%
LGNDLigand Pharmaceuticals Inc - Class B37.91-241.82%
APLSApellis Pharmaceuticals Inc39.02-245.97%
BMRNBiomarin Pharmaceutical Inc42.21-257.91%
KRYSKrystal Biotech Inc45.34-269.62%
ONCBeiGene Ltd69.54-360.14%
PHARPharming Group N.V.75.03-380.66%
TECHBio-Techne Corp101.96-481.42%
VCELVericel Corp109.92-511.20%
ALNYAlnylam Pharmaceuticals Inc117.96-541.29%
GMABGenmab140.29-624.81%
TLXTelix Pharmaceuticals Ltd162.15-706.60%
CORTCorcept Therapeutics Inc212.86-896.28%